|
|
||||||||
Alcon Research Ltd, 6201 South Freeway, R0-17, Fort Worth, TX 76134-2099, USA
Correspondence
David W. Stroman
David.Stroman{at}alconlabs.com
| ABSTRACT |
|---|
|
|
|---|
The GenBank/EMBL/DDBJ accession number for the 16S rRNA gene sequence of MCC10330T is AY953147.
Tables detailing the biochemical and phenotypic characteristics of individual novel strains and the cellular fatty acid composition of the novel strains and related Pseudomonas species are available as supplementary material in IJSEM Online.
| MAIN TEXT |
|---|
|
|
|---|
Novel pseudomonads were recovered from the ears of patients enrolled in anti-infective clinical studies. In total, 41 novel pseudomonads were recovered from ears of patients diagnosed with acute otitis externa (n=34), otitis media with otorrhoea drainage through a tympanostomy tube (n=6) and chronic suppurative otitis media (n=1). A brief description of the source of 11 representative isolates is listed in Table 1
. At clinical examination, a swab was used to sample each patient's ears, and the swabs were then immediately placed into transport media. Swabs were removed from transport media and cultured onto various media to obtain viable colonies and then subcultured to obtain a pure culture. Isolated colonies were transferred to trypticase soy broth supplemented with 10 % glycerol and stored in liquid nitrogen. Bacteria were thawed and cultured onto blood agar prior to genetic or phenotypic analyses. DNADNA hybridization, comparative 16S rRNA gene sequencing and phenotypic analysis identified these organisms as members of a novel Pseudomonas species. The novel pseudomonads were compared with the type strains of Pseudomonas alcaligenes, P. aeruginosa, P. citronellolis, P. multiresinovorans, P. nitroreducens, P. resinovorans and P. stutzeri, which were acquired from the ATCC.
|
|
|
|
The 11 representative novel strains were evaluated for phenotypic characteristics and compared with the type strains of P. aeruginosa, P. citronellolis and P. stutzeri (Table 2
; results for the individual novel strains are given in Supplementary Table S1 in IJSEM Online). Carbon substrate utilization was determined using the Biolog GN MicroPlate System and VITEK32 (bioMérieux). The presence of oxidase, catalase and urease activity, production of fluorescent pigments, hydrolysis of Tween 80, aesculin, starch and casein, motility in semisolid media, tolerance of NaCl and minimal and maximal temperature range were all assayed according to standard procedures. Cells of the novel strains were motile, Gram-negative, non-spore-forming rods occurring as single cells. Growth occurred at temperatures of 745 °C, but no growth was observed at 4 or 47 °C. Growth occurred on solid media supplemented with 04 % NaCl (w/v), but not at higher salinity. Growth was observed in media only at pH 510. The majority of the novel strains (10 of 11) failed to produce pyocyanin or fluorescein, whereas both P. aeruginosa and P. citronellolis produced these pigments. Each strain had positive reactions for oxidase and catalase, but all were negative for urease. The novel strains were relatively homogeneous in their metabolic characteristics. They differed from the reference strains in utilization of glycerol, D-gluconic acid, itaconic acid, D-fructose, D-mannitol, acetic acid, cytosine,
-phenylethylamine and sebacic acid.
|
7c (32·9 %), C16 : 0 (26·9 %), C12 : 0 (9·1 %), C12 : 0 3-OH (4·0 %) and C10 : 0 3-OH (2·8 %). C12 : 0 3-OH is consistently found in members of the genus Pseudomonas sensu stricto (Oyauzu & Komagata, 1983
Minimal inhibitory concentrations (MIC) were determined using the National Committee for Clinical Laboratory Standards broth microdilution method (NCCLS, 2003
). Microdilution plates (96 wells) contained specific concentrations of antibiotic incorporated into the wells (PML Microbiologicals). Microdilution plates were inoculated with approximately 5x105 c.f.u. bacteria ml1 and incubated overnight at 35 °C. The MIC was defined as the lowest concentration of antibiotic that inhibits growth of an organism as determined by lack of turbidity. The concentrations of antibiotic that inhibited the growth of 50 % (MIC50) or 90 % (MIC90) of the number of novel strains tested were determined. Antibiotic plates were analysed using a 96-well microplate reader (Dynatech Laboratories) at a wavelength of 590 nm and further analysed by visual inspection to determine turbidity. The novel strains exhibited similar antibiotic susceptibility profiles (Table 3
). The isolates were susceptible to aminoglycosides (tobramycin, neomycin, gentamicin), fluoroquinolones (ciprofloxacin, ofloxacin, moxifloxacin) and polymyxin B. However, piperacillin, erythromycin, tetracycline, chloramphenicol, trimethoprim and sulfamethoxazole had minimal ability to inhibit growth of the organisms.
|
Cells are Gram-negative, motile rods. Colonies on trypticase soy agar are circular, concave and non-pigmented. Colonies grown on trypticase soy agar supplemented with 5 % sheep blood are not haemolytic. Growth occurs at 745 °C, pH 510 and in the presence of up to 4 % NaCl. Colonies typically do not produce fluorescent pigment, and all strains are positive for oxidase and catalase, but negative for urease. Tween 80 and gelatin are hydrolysed, but casein and aesculin are not. Utilizes glycogen,
-D-glucose, acetic acid, citric acid, formic acid, lactic acid, propionic acid, succinic acid, D-alanine, L-alanine, L-arginine, L-asparagine, L-aspartic acid, L-glutamic acid, L-histidine, L-leucine, L-ornithine, L-proline, L-serine,
-aminobutyric acid, phenylethylamine and putrescine. None of the strains utilizes N-acetyl-D-galactosamine, N-acetyl-D-glucosamine, adonitol, D-arabitol, L-arabinose, i-erythritol, myo-inositol, glycerol, D-mannitol, D-sorbitol, xylitol, D-fructose, L-fucose, D-galactose, gentiobiose,
-D-lactose, maltose, D-mannose, D-melibiose, D-raffinose, L-rhamnose, sucrose, D-trehalose, turanose, D-xylose, D-galacturonic acid, D-gluconic acid, D-glucuronic acid, itaconic acid, glucuronamide, L-phenylalanine, D-serine, inosine, uridine, thymidine, cytosine or sebacic acid. The predominant cellular fatty acids are C18 : 1
7c, C16 : 0, C12 : 0, C12 : 0 3-OH and C10 : 0 3-OH. Susceptible to aminoglycosides, fluoroquinolones and polymyxin B, but resistant to piperacillin, erythromycin, tetracycline, chloramphenicol, trimethoprim and sulfamethoxazole. The DNA G+C content of the type strain is 67·9 mol%.
The type strain, MCC10330T (=ATCC BAA-1130T=DSM 17224T), and other strains were isolated from the ears of patients with acute otitis externa, acute otitis media with otorrhoea and chronic suppurative otitis media.
| REFERENCES |
|---|
|
|
|---|
Anzai, Y., Kim, H., Park, J., Wakabayashi, H. & Oyaizu, H. (2000). Phylogenetic affiliation of the pseudomonads based on 16S rRNA sequence. Int J Syst Evol Microbiol 50, 15631589.[Abstract]
Cashion, P., Holder-Franklin, M. A., McCully, J. & Franklin, M. (1977). A rapid method for the base ratio determination of bacterial DNA. Anal Biochem 81, 461466.[CrossRef][Medline]
De Ley, J., Cattoir, H. & Reynaerts, A. (1970). The quantitative measurement of DNA hybridization from renaturation rates. Eur J Biochem 12, 133142.[Medline]
Huß, V. A. R., Festl, H. & Schleifer, K. H. (1983). Studies on the spectrophotometric determination of DNA hybridization from renaturation rates. Syst Appl Microbiol 4, 184192.
Ivanova, E., Gorshkova, N., Sawabe, T. & 8 other authors (2002). Pseudomonas extremorientalis sp. nov., isolated from a drinking water reservoir. Int J Syst Evol Microbiol 52, 21132120.[Abstract]
Kersters, K., Ludwig, W., Vancanneyt, M., De Vos, P., Gillis, M. & Schleifer, K. H. (1996). Recent changes in the classification of the pseudomonads: an overview. Syst Appl Microbiol 19, 465477.
Migula, W. (1894). Ube rein neues System der Bakterien. Arb Bakteriol Inst Karlsruhe 1, 235238 (in German).
Munsch, P., Alatossava, T., Marttinen, N., Meyer, J., Christen, R. & Gardan, L. (2002). Pseudomonas costantinii sp. nov., another causal agent of brown blotch disease, isolated from cultivated mushroom sporophores in Finland. Int J Syst Evol Microbiol 52, 19731983.[Abstract]
NCCLS (2003). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th edn. Approved Standard M7-A6. Wayne, PA: National Committee for Clinical Laboratory Standards.
Oyauzu, H. & Komagata, K. (1983). Grouping of Pseudomonas species on the basis of cellular fatty acid composition and the quinone system with special reference to 3-hydroxy fatty acids. J Gen Appl Microbiol 29, 1740.
Palleroni, N. J. (1984). Genus I. Pseudomonas Migula 1894
. In Bergey's Manual of Systematic Bacteriology, vol. 1, pp. 141199. Edited by N. R. Krieg & J. G. Holt. Baltimore: Williams & Wilkins.
Palleroni, N. J., Kunisawa, R., Contopoulou, R. & Doudoroff, M. (1973). Nucleic acid homologies in the genus Pseudomonas. Int J Syst Bacteriol 23, 333339.
Roland, P. & Stroman, D. (2002). Microbiology of acute otitis externa. Laryngoscope 112, 11661177.[CrossRef][Medline]
Sikorski, J., Stackebrandt, E. & Wackernagel, W. (2001). Pseudomonas kilonensis sp. nov., a bacterium isolated from agricultural soil. Int J Syst Evol Microbiol 51, 15491555.[Abstract]
Wayne, L. G., Brenner, D. J., Colwell, R. R. & 9 other authors (1987). Report of the ad hoc committee on reconciliation of approaches to bacterial systematics. Int J Syst Bacteriol 37, 463464.
This article has been cited by other articles:
![]() |
L. Tvrzova, P. Schumann, C. Sproer, I. Sedlacek, Z. Pacova, O. Sedo, Z. Zdrahal, M. Steffen, and E. Lang Pseudomonas moraviensis sp. nov. and Pseudomonas vranovensis sp. nov., soil bacteria isolated on nitroaromatic compounds, and emended description of Pseudomonas asplenii. Int J Syst Evol Microbiol, November 1, 2006; 56(Pt 11): 2657 - 2663. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |